new_0222_0384|IPSC|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0384|IPSC|1|Century Therapeutics Inc Total Current Assets (Quarterly) (USD)|Century Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Century Therapeutics Inc Inventories (Quarterly) (USD)|Century Therapeutics Inc Net PP&E (Quarterly) (USD)|Century Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Century Therapeutics Inc Total Liabilities (Quarterly) (USD)|Century Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Century Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Century Therapeutics Inc Total Deposits (Quarterly) (USD)|Century Therapeutics Inc Book Value (Quarterly) (USD)|Century Therapeutics Inc Retained Earnings (Quarterly) (USD)|Century Therapeutics Inc Treasury Stock (Quarterly) (USD)|Century Therapeutics Inc EV to Revenues|Century Therapeutics Inc EV to Earnings|Century Therapeutics Inc EV to Free Cash Flow|Century Therapeutics Inc EV to Assets (Quarterly)|Century Therapeutics Inc PS Ratio|Century Therapeutics Inc PE Ratio|Century Therapeutics Inc Price to Book Value|Century Therapeutics Inc PEG Ratio|Century Therapeutics Inc Debt to Equity Ratio|Century Therapeutics Inc Dividend Yield|Century Therapeutics Inc Shareholder Yield (TTM)|Century Therapeutics Inc Percent of Shares Outstanding Short|Century Therapeutics Inc Total Receivables (Quarterly) (USD)|Century Therapeutics Inc Total Payables (Quarterly) (USD)|Century Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Century Therapeutics Inc Return on Invested Capital|Century Therapeutics Inc Quality Ratio Score|Century Therapeutics Inc Momentum Score|Century Therapeutics Inc Beta (1Y)|Century Therapeutics Inc Sustainable Growth Rate (TTM)|Century Therapeutics Inc Institutional Investor Ownership Percentage|Century Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Century Therapeutics Inc Total Employees (Annual)|Century Therapeutics Inc EPS Diluted (Quarterly) (USD)|Century Therapeutics Inc SG&A Expense (Quarterly) (USD)|Century Therapeutics Inc Shares Outstanding|Century Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Century Therapeutics Inc Ordinary Shares Number (Quarterly)|Century Therapeutics Inc Payout Ratio|Century Therapeutics Inc Quick Ratio (Quarterly)|Century Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Century Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Century Therapeutics Inc Effective Tax Rate (TTM)|Century Therapeutics Inc Return on Equity|Century Therapeutics Inc Net Income (TTM) (USD)|Century Therapeutics Inc Revenue (TTM) (USD)|Century Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Century Therapeutics Inc Revenue (Quarterly) (USD)|Century Therapeutics Inc Gross Profit (Quarterly) (USD)|Century Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Century Therapeutics Inc Net Income (Quarterly) (USD)|Century Therapeutics Inc Net Interest Income (Quarterly) (USD)|Century Therapeutics Inc Price (USD)|Century Therapeutics Inc Total Return Price (USD)|Century Therapeutics Inc Enterprise Value (USD)|Century Therapeutics Inc 30-Day Average Daily Volume|Century Therapeutics Inc 1 Year Price Returns (Daily)|Century Therapeutics Inc Short Interest|Century Therapeutics Inc PE Ratio (Forward)|Century Therapeutics Inc PE Ratio (Forward 1y)|Century Therapeutics Inc PS Ratio (Forward)|Century Therapeutics Inc PS Ratio (Forward 1y)|Century Therapeutics Inc Quarterly EPS Estimates (USD)|Century Therapeutics Inc Quarterly Revenue Estimates (USD)|Century Therapeutics Inc Quarterly EPS Surprise|Century Therapeutics Inc Quarterly Revenue Surprise|Century Therapeutics Inc Quarterly Actual EPS (USD)|Century Therapeutics Inc Quarterly Actual Revenue (USD)|Century Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Century Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Century Therapeutics Inc Price Target (USD)|Century Therapeutics Inc Consensus Recommendation|Century Therapeutics Inc Price Target Num Estimates|Century Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Century Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Century Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Century Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Century Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Century Therapeutics Inc Land and Improvements (Quarterly) (USD)|Century Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Century Therapeutics Inc Other Properties (Quarterly) (USD)|Century Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0384|IPSC|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0384|IPSC|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0384|IPSC|5|91|91||91|90|91|91|91||91|91||||1.44117647059||||1.43827160494|||1.44117647059||15.3571428571|91|91|91||||||30.7142857143|91.3333333333|61|91.3333333333|91.3333333333|24.3333333333||91|||91.3333333333|91.3333333333|||91|||||91.3333333333|91.3333333333|91.3333333333|1.44117647059|1.44117647059|1.44117647059|1.43971631206||15.3571428571|||1.43333333333|1.43333333333|91.5|91.5|92||92|92|25.8571428571|30.1666666667|36.5|16.8461538462|36.5|22.625|25.8571428571|91.3333333333|91.3333333333|91.3333333333|||91|91||
new_0222_0384|IPSC|6|3|3||3|1|3|3|3||3|3||||170||||162|||170||14|3|3|3||||||7|6|1|6|6|6||3|||6|6|||3|||||6|6|6|170|170|170|141||14|||30|30|6|6|1||1|1|7|6|6|13|6|8|7|6|6|6|||3|3||
new_0222_0384|IPSC|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0384|IPSC|202003||||||||||||||||||||||||||||||||||41.8037||-0.2314|2.05||||||-0.2314|||||||||-9.673|-9.673|||||||||||||||||||||||||7.943|0.2|||||||
new_0222_0384|IPSC|202006||||||||||||||||||||||||||||||||||41.8037||-0.366|2.31||||||-0.2531|||||||||-15.301|-15.301|0.215||||||||||||||||||||||||8.484|0.282|||||||
new_0222_0384|IPSC|202009||||||||||||||||||||||||||||||||||41.8037||-0.3127|2.319||||||-0.3127|||||||||-13.07|-13.07|0.061||||||||||||||||||||||||10.812|0.41|0.045||||||
new_0222_0384|IPSC|202012|78.797|75.753||15.385|9.392|213.188|12.112|201.076||-106.412|-292.342||||||||||||||0.908|8.082|0.001|||||||41.8037||-0.3715|2.816|||54.8246|||-0.3715||||-53.575|||||-15.531|-15.531|-0.977||||||||||||||||||||||||12.442|0.51|0.336|||8.941|0.29||
new_0222_0384|IPSC|202103|185.299|182.942||20.657|12.46|377.612|12.912|364.7||-91.557|-310.69||||||||||||||0.137|8.816|0.001|||||||41.8037|107|-0.44|2.688|||54.8246|||-0.44|-0.047|||-62.25|||||-18.348|-18.348|-0.314||||||||||||||||||||||||15.374|0.718|0.314|||11.427|0.381||
new_0222_0384|IPSC|202106|402.611|397.567||46.713||48.033|21.225|26.808||447.597|-333.963||||-14.7306||||3.5662|||||0.9309|0.137|13.427|0.005||||||48.2261|12.0446|121|-1.93|4.088|54.4041||54.4041|||-1.93|-221.952|||-70.222|||||-23.273|-23.273|-0.252|29.34|29.34|1208.4373|339607.9667||506443|||||-0.379||-409.302||-1.93||||36.25|1.5|4|-1.7454|-1.7798|18.933|0.935|0.242|||15.294|13.149|29.15|24.8
new_0222_0384|IPSC|202109|300.398|295.152||60.663||46.737|19.868|26.869||422.988|-359.972||||-10.0856||||3.2502|||||2.6262|0.191|11.644|0.005||||||74.95|54.4727||-0.48|6.282|54.6414||54.6414|||-0.48|0.467|||-83.161|||||-26.009|-26.009|-0.182|25.16|25.16|1089.4906|190908.2667||1434994|||||-0.4227||-13.5638||-0.48||||36|1.5|4|-3.9596|-1.829|19.545|1.044|0.245|||15.144|13.987|22.47|19.11
new_0222_0384|IPSC|202112|||||||||||||||-5.3814||||2.0488|||||4.0377|||||||||75.8189||||||||||||||||||||||15.86|15.86|581.3256|132082.5333||2206281|||57.2482|104.3955|-0.4928||||||12.4367|6.82|36|1.5|4|-3.3425|-2.1316||||||||13.03|12.2
new_0222_0384|IPSC|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.49|10||||||||||||||||||||
new_0222_0384|IPSC|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.51|2.8||||||||||||||||||||
new_0222_0384|IPSC|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.54|2.95||||||||||||||||||||
new_0222_0384|IPSC|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.58|2.9||||||||||||||||||||